Recents
Work with Haemnet
Opportunities to work with Haemnet If you’ve been following us on social media, you may have spotted us mentioning our…
2019 in review
So we are in to a new decade. Roll on 2020!.. However, the inevitable new year buzz fills social media…
Haemnet Headed to Uganda
With the days getting shorter and colder, the Christmas advert wars underway and Christmas songs being played everywhere, it’s no…
Joint Bleeds in Adults: Not All Pharmacokinetics
Commentary by David Stephensen (PhD), Physiotherapist, Kent Haemophilia & Thrombosis Centre and the Haemophilia Centre, Royal London Hospital
If you don’t ask, you don’t get!
Few would disagree that recent decades have witnessed massive advances in the care offered to some people with bleeding disorders.…
Baby steps to a new world of treatment
With so much happening in haemophilia care these days, there’s no better way to catch up with the latest developments…
Personalising Care in Transition
When caring for patients with lifelong chronic diseases we have traditionally used the term ‘transition’ to refer to the period…
More questions than answers
So, the long-awaited news is out: NHS England have approved the use of emicizumab for non-inhibitor patients. Fabulous news for…
48 Hours in Saudi Arabia
I was invited to be part of an international faculty at a Pan Gulf meeting on bleeding disorders which was…
Where is Gene Therapy?
Haemophilia nurses are increasingly being asked about gene therapy so this overview of the science and evidence from clinical trials…
The first Womens and Bleeding Disorders conference comes to a close – day 3
Quality of life is difficult to measure scientifically, which is why published research is often incomprehensible to the non-specialist –…
Time to refocus? – EHC Women and Bleeding Disorders Conference Day 2
The second day of the EHC conference on women and bleeding disorders looked, from the agenda, to be all about…